Company Filing History:
Years Active: 1993-1996
Title: **Mark D Clymer: Innovator in Monoclonal Antibodies**
Introduction
Mark D Clymer is a prominent inventor based in Norristown, PA, who has made significant contributions to the field of biotechnology through his innovative work on monoclonal antibodies. With two patents to his name, Clymer’s inventions are particularly focused on diagnosing plant infections caused by specific fungal pathogens.
Latest Patents
Clymer's latest patents include groundbreaking inventions in monoclonal antibodies aimed at combating diseases in plant materials. His first invention revolves around monoclonal antibodies targeted at Mycosphaerella species. This invention provides a method for creating a hybridoma cell line capable of producing these specific antibodies, alongside methods and kits designed for diagnosing Mycosphaerella infections in plants.
Additionally, he holds a patent for monoclonal antibodies that specifically react to Leptosphaeria nodorum. This invention similarly involves a method for developing hybridoma cell lines that produce antibodies against this pathogen and also offers diagnostic tools for identifying infections in plant materials.
Career Highlights
Mark D Clymer is affiliated with the Ciba-Geigy Corporation, where he has channeled his expertise into pioneering efforts in plant pathology through biotechnology. His work at Ciba-Geigy has positioned him as a significant contributor to advancements in agricultural health and disease management.
Collaborations
Clymer collaborates with notable professionals in his field, including Frank P Petersen and Sally A Miller. These collaborations have enhanced the depth and impact of his research, leading to greater innovations and solutions in plant disease diagnostics.
Conclusion
Mark D Clymer's contributions to monoclonal antibody technology represent a vital asset in the ongoing battle against plant diseases. His innovative inventions not only advance scientific knowledge but also provide practical solutions for agricultural challenges, showcasing the critical role of inventors in the realm of biotechnology.